Cheryl is Head of Global Commercial Strategy with a focus on product and portfolio strategy, pricing and market access, digital, data and analytics, and digital health innovation - to help make HIV a smaller part of people's lives.

Cheryl began her biopharmaceutical career at GSK in Canada. Her first significant leadership role was leading marketing and sales in Canada, modernising customer engagement for accelerated growth across a broad range of medicines and vaccines. In 2011, Cheryl relocated to the US as a member of the GSK US Executive Team, with P&L accountability for Primary Care businesses and leadership of US Pharma operations. Signature contributions included game-changing moves that pivoted the performance trajectory, the launch of new medicines with industry-leading performance, divestments for profit growth, and a relentless energy for team engagement and talent development.

Cheryl holds a Degree in Pharmacy from the University of Toronto, a Master’s in Business Administration from the Schulich School of Business, York University in Toronto, and executive development from Harvard, Wharton and Columbia.